EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Skin barrier: new therapeutic targets for chronic kidney disease‐associated pruritus – a narrative review

Siyue Zhai iD, Lei Chen, Hua Liu, Meng Wang, Jinhong Xue, Xue Zhao, Hongli Jiang

International Journal of Dermatology · 2024

DOI: 10.1111/ijd.17254 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Dermatology, 2024. Verfasst von Siyue Zhai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Nephrology and Blood Purification, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Pruritus, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Natural Science Foundation of Shaanxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current incidence of chronic kidney disease‐associated pruritus (CKD‐aP) in patients with end‐stage renal disease (ESRD) is approximately 70%, especially in those receiving dialysis, which negatively affects their work and private lives. The CKD‐aP pathogenesis remains unclear, but uremic toxin accumulation, histamine release, and opioid imbalance have been suggested to lead to CKD‐aP. Current therapeutic approaches, such as opioid receptor modulators, antihistamines, and ultraviolet B irradiation, are associated with some limitations and adverse effects. The skin barrier is the first defense in preventing external injury to the body. Patients with chronic kidney disease often experience itch due to the damaged skin barrier and reduced secretion of sweat and secretion from sebaceous glands. Surprisingly, skin barrier‐repairing agents repair the skin barrier and inhibit the release of inflammatory cytokines, maintain skin immunity, and ameliorate the micro‐inflammatory status of afferent nerve fibers. Here, we summarize the epidemiology, pathogenesis, and treatment status of CKD‐aP and explore the possibility of skin barrier repair in CKD‐aP treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PruritusRenal Insufficiency, ChronicHumansSkinHistamine AntagonistsKidney Failure, ChronicRenal DialysisNarcotic AntagonistsUltraviolet Therapy

Stichwörter der Autor:innen

CKD‐aPchronic kidney diseaseend‐stage renal diseasepruritusskin barriertreatment

Substanzen

Histamine AntagonistsNarcotic Antagonists

Autor:innen und Institutionen

  • Department of Critical Care Nephrology and Blood Purification, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Central for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

ORCID-Profile: Siyue Zhai

Förderung

  • Natural Science Foundation of Shaanxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhai, S., Chen, L., Liu, H., Wang, M., Xue, J., Zhao, X., & Jiang, H. (2024). Skin barrier: new therapeutic targets for chronic kidney disease‐associated pruritus – a narrative review. International Journal of Dermatology. https://doi.org/10.1111/ijd.17254

Vancouver

Zhai S, Chen L, Liu H, Wang M, Xue J, Zhao X, et al. Skin barrier: new therapeutic targets for chronic kidney disease‐associated pruritus – a narrative review. International Journal of Dermatology. 2024. doi:10.1111/ijd.17254

BibTeX
@article{Zhai2024,
  author = {Zhai, Siyue and Chen, Lei and Liu, Hua and Wang, Meng and Xue, Jinhong and Zhao, Xue and Jiang, Hongli},
  title = {Skin barrier: new therapeutic targets for chronic kidney disease‐associated pruritus – a narrative review},
  journal = {International Journal of Dermatology},
  year = {2024},
  doi = {10.1111/ijd.17254}
}
Kostenlos starten →